50-172-6069

TUSC4 Rabbit anti-Human, Mouse, Rat, Polyclonal, Proteintech

Manufacturer: Proteintech Group Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-172-6069-Each-of-1 In Stock ₹ 44,150.23

50-172-6069 - Each of 1

₹ 44,150.23

In Stock

Quantity

1

Base Price: ₹ 44,150.23

GST (18%): ₹ 7,947.041

Total Price: ₹ 52,097.271

Antigen

TUSC4

Classification

Polyclonal

Conjugate

Unconjugated

Gene

NPRL2

Gene Alias

G21 protein, Gene 21 protein, tumor suppressor candidate 4, TUSC4

Host Species

Rabbit

Purification Method

Antigen Affinity Chromatography

Regulatory Status

RUO

Gene ID (Entrez)

10641, 363138, 56032

Content And Storage

-20°C

Form

Liquid

Applications

Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot

Concentration

0.26 mg/mL

Formulation

PBS with 50% glycerol and 0.1% sodium azide; pH 7.3

Gene Accession No.

Q8WTW4, Q9WUE4

Gene Symbols

Nprl2

Immunogen

TUSC4 Fusion Protein Ag0210

Quantity

150 μL

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Product Type

Antibody

Isotype

IgG

Related Products

Img

Proteintech Group Inc

50-172-6117

--

Img

Proteintech Group Inc

50-172-6011

--

Img

Proteintech Group Inc

50-172-6227

--

Img

Proteintech Group Inc

50-172-5993

--

Img

Proteintech Group Inc

50-172-6143

--

Img

Proteintech Group Inc

50-172-6134

--

Img

Proteintech Group Inc

50-172-6268

--

Img

Proteintech Group Inc

50-172-6016

--

Description

  • NPRL2, also known as TUSC4 (tumor suppressor candidate 4), is a 380 amino acid protein that contains a bipartite nuclear localization signal and a granulin protein-binding domain
  • It is highly expressed in skeletal muscle, followed by brain, liver and pancreas, with lower expression in lung, kidney, placenta and heart
  • NPRL2 is also expressed in most lung cancer cell lines and may be involved in tumor suppression
  • NPRL2 may play a role in mismatch repair, cell cycle checkpoint signaling and activation of apoptotic pathways
  • It may also enhance the therapeutic efficacy of chemotherapy drugs such as cis-platin by resensitizing patients resistant to cisplatin treatment
  • The gene encoding NPRL2 is conserved between species and is expressed as two isoforms due to alternative splicing events.